Clinical Outcomes of Secondary Prophylactic Granulocyte Colony-Stimulating Factors in Breast Cancer Patients at a Risk of Neutropenia with Doxorubicin and Cyclophosphamide-Based Chemotherapy

Clinical Outcomes of Secondary Prophylactic Granulocyte Colony-Stimulating Factors in Breast Cancer Patients at a Risk of Neutropenia with Doxorubicin and Cyclophosphamide-Based Chemotherapy

Doxorubicin and cyclophosphamide (AC)-based chemotherapy has been a standard regimen for early-stage breast cancer (ESBC) with an intermediate risk (10–20%) of febrile neutropenia (FN). Secondary prophylaxis of granulocyte colony-stimulating factor (G-CSF) is considered in patients receiving AC-base...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jae Hee Choi, Min Jung Geum, Ji Eun Kang, Nam Gi Park, Yun Kyoung Oh, Sandy Jeong Rhie
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
secondary prophylaxis
granulocyte colony-stimulating factor
breast cancer
neutropenia
adjuvant chemotherapy
doxorubicin
Medicine
R
Pharmacy and materia medica
RS1-441
Acceso en línea:https://doaj.org/article/918773c20d6940ac9234100a7cc7ce1a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/918773c20d6940ac9234100a7cc7ce1a

Ejemplares similares